Giorgio Facchetti

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

Molecules (Basel, Switzerland)

Inorganic chemistry

Dalton transactions (Cambridge, England : 2003)

Chemical communications (Cambridge, England)

università degli studi di milano

università degli studi di milano (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

università degli studi di milano Jul 1o 2015

Italy

post doc fellowship :: Department of Pharmaceutical Sciences

Education History

università degli studi di milano

Italy

PHD :: Department of Pharmaceutical Sciences

Publications

Giulia Coffetti, Martina Moraschi, Giorgio Facchetti, Isabella Rimoldi
The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives. Molecules (Basel, Switzerland) 28 (8) (2023)
Giorgio Facchetti, Francesca Neva, Giulia Coffetti, Isabella Rimoldi
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors. Molecules (Basel, Switzerland) 28 (4) (2023)
Giulia Coffetti, Martina Moraschi, Giorgio Facchetti, Isabella Rimoldi
The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives. Molecules (Basel, Switzerland) 28 (8) (2023)
Giorgio Facchetti, Francesca Neva, Giulia Coffetti, Isabella Rimoldi
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors. Molecules (Basel, Switzerland) 28 (4) (2023)
Giulia Coffetti, Martina Moraschi, Giorgio Facchetti, Isabella Rimoldi
The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives. Molecules (Basel, Switzerland) 28 (8) (2023)
Giulia Coffetti, Martina Moraschi, Giorgio Facchetti, Isabella Rimoldi
The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives. Molecules (Basel, Switzerland) 28 (8) (2023)
Giorgio Facchetti, Francesca Neva, Giulia Coffetti, Isabella Rimoldi
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors. Molecules (Basel, Switzerland) 28 (4) (2023)
Giorgio Facchetti, Francesca Neva, Giulia Coffetti, Isabella Rimoldi
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors. Molecules (Basel, Switzerland) 28 (4) (2023)
Giorgio Facchetti, Francesca Neva, Giulia Coffetti, Isabella Rimoldi
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors. Molecules (Basel, Switzerland) 28 (4) (2023)
Gloria Mazzone, Stefano Scoditti, Rossella Caligiuri, Loredana Ricciardi, Emilia Sicilia, Maria Giovanna Lupo, Isabella Rimoldi, Nicolas Godbert, Massimo La Deda, Andreea Ionescu, Mauro Ghedini, Iolinda Aiello, Giorgio Facchetti
Cytotoxicity of Alizarine versus Tetrabromocathecol Cyclometalated Pt(II) Theranostic Agents: A Combined Experimental and Computational Investigation. Inorganic chemistry 61 (18) (2022)
Rossella Caligiuri, Giuseppe Di Maio, Nicolas Godbert, Francesca Scarpelli, Angela Candreva, Isabella Rimoldi, Giorgio Facchetti, Maria Giovanna Lupo, Emilia Sicilia, Gloria Mazzone, Fortuna Ponte, Isabella Romeo, Massimo La Deda, Alessandra Crispini, Renata De Rose, Iolinda Aiello
Curcumin-based ionic Pt(II) complexes: antioxidant and antimicrobial activity. Dalton transactions (Cambridge, England : 2003) 51 (43) (2022)
Francesca Sacco, Matteo Tarchi, Giarita Ferraro, Antonello Merlino, Giorgio Facchetti, Isabella Rimoldi, Luigi Messori, Lara Massai
Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands. International journal of molecular sciences 22 (19) (2021)
Giorgio Facchetti, Raffaella Bucci, Marco Fusè, Emanuela Erba, Raffaella Gandolfi, Sara Pellegrino, Isabella Rimoldi
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex. Inorganic chemistry 60 (5) (2021)
Luca G Iacovino, Luca Pinzi, Giorgio Facchetti, Beatrice Bortolini, Michael S Christodoulou, Claudia Binda, Giulio Rastelli, Isabella Rimoldi, Daniele Passarella, Maria Luisa Di Paolo, Lisa Dalla Via
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B. ACS medicinal chemistry letters 12 (7) (2021)
Valentina Cocce, Isabella Rimoldi, Giorgio Facchetti, Emilio Ciusani, Giulio Alessandri, Lucia Signorini, Francesca Sisto, Aldo Giannì, Francesca Paino, Augusto Pessina
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma. Pharmaceutics 13 (12) (2021)
Emanuela Corsini, Giorgio Facchetti, Sara Esposito, Ambra Maddalon, Isabella Rimoldi, Michael S Christodoulou
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia-derived cells: Role of PKCβ. Archiv der Pharmazie 353 (7) (2020)
Marco Fusè, Isabella Rimoldi, Giorgio Facchetti, Sergio Rampino, Vincenzo Barone
Exploiting coordination geometry to selectively predict the σ-donor and π-acceptor abilities of ligands: a back-and-forth journey between electronic properties and spectroscopy. Chemical communications (Cambridge, England) 54 (19) (2018)

Giorgio Facchetti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giorgio Facchetti